APA

Fischer M. A., Friedlander S. Y., Arrate M. P., Chang H., Gorska A. E., Fuller L. D., Ramsey H. E., Kashyap T., Argueta C., Debler S., Byrne M., Villaume M. T., Shaver A. C., Senapedis W., Landesman Y., Baloglu E., Shacham S. & Savona M. R. (20210514). Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies. : Blood advances.

Chicago

Fischer Melissa A, Friedlander Sharon Y, Arrate Maria P, Chang Hua, Gorska Agnieszka E, Fuller Londa D, Ramsey Haley E, Kashyap Trinayan, Argueta Christian, Debler Sophie, Byrne Michael, Villaume Matthew T, Shaver Aaron C, Senapedis William, Landesman Yosef, Baloglu Erkan, Shacham Sharon and Savona Michael R. 20210514. Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies. : Blood advances.

Harvard

Fischer M. A., Friedlander S. Y., Arrate M. P., Chang H., Gorska A. E., Fuller L. D., Ramsey H. E., Kashyap T., Argueta C., Debler S., Byrne M., Villaume M. T., Shaver A. C., Senapedis W., Landesman Y., Baloglu E., Shacham S. and Savona M. R. (20210514). Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies. : Blood advances.

MLA

Fischer Melissa A, Friedlander Sharon Y, Arrate Maria P, Chang Hua, Gorska Agnieszka E, Fuller Londa D, Ramsey Haley E, Kashyap Trinayan, Argueta Christian, Debler Sophie, Byrne Michael, Villaume Matthew T, Shaver Aaron C, Senapedis William, Landesman Yosef, Baloglu Erkan, Shacham Sharon and Savona Michael R. Venetoclax response is enhanced by selective inhibitor of nuclear export compounds in hematologic malignancies. : Blood advances. 20210514.